logo
Food expert warns ‘one of the riskiest items in the grocery store' seems healthy but can make you deathly ill

Food expert warns ‘one of the riskiest items in the grocery store' seems healthy but can make you deathly ill

New York Post11 hours ago

Your good health habit could actually get you seriously sick — and you wouldn't know until it's too late.
While experts unanimously agree that we should all be eating more fresh, whole foods, a food policy professor has a warning: Danger lurks in your grocery store's produce aisle.
Not all fruits and veggies are created equal, and a popular choice for easy meals that save you time could come with the price of contamination.
3 Prewashed bagged greens are one of the riskiest items in the grocery store.
Scott Habermann – stock.adobe.com
'Prewashed bagged greens remain one of the riskiest items in the grocery store,' Darin Detwiler, a professor of food policy at Northeastern University and author of 'Food Safety: Past, Present, and Predictions,' told Huffington Post.
'When you look at past outbreaks, bagged salads have been a leading cause of foodborne illness, with some outbreaks resulting in hospitalizations, kidney failure, and even death.'
Those pre-mixed bagged salads can harbor pathogens like listeria, salmonella, and E. coli and pose a higher risk for contamination through the supply chain and are among the worst offenders for food safety.
According to the Centers for Disease Control and Prevention, food poisoning symptoms from bacteria like listeria or E. coli — which cause infections in the gastrointestinal tract — include nausea, vomiting, fever, abdominal pain, and diarrhea.
According to a 2024 report in the Journal of Foodborne Illness, leafy greens are credited with 'up to 9.2% of known pathogen-caused foodborne illnesses' in the U.S, resulting in over 2.3 million cases of illness each year.
What makes these speedy veggies particularly dicey is that heat is required to kill pathogens — and salads are typically eaten raw, making it difficult to reduce the risk of foodborne illness once they reach consumers.
Contamination of these mean greens can occur at different stages of production.
Produce can be contaminated during lettuce collection by pathogens in the water, soil, or air, or by wild or domesticated animals. Leafy greens are sometimes grown near large-scale cattle operations, a proximity that increases the likelihood that E. coli, salmonella, and listeria could be introduced through contaminated irrigation water.
3 Produce can be contaminated during collection by pathogens in the water, soil, or air, or by wild or domesticated animals.
Pormezz – stock.adobe.com
Detwiler cites manure lagoons, large pits where livestock waste is stored, as a common source of food contamination.
'Runoff from manure lagoons can seep into irrigation canals and contaminate fields with deadly bacteria like E. coli,' he said.
Post-harvest, lettuce can be compromised through human handling, contaminated equipment, or water used to remove soil.
Typically, lettuces from various farms are processed in a centralized area, meaning your bag of greens is more of a menagerie of fetid potential than a single source.
'Greens from different farms are mixed, washed, and packaged together, so one contaminated leaf can impact thousands of bags across multiple states,' said Detwiler.
3 Consider ditching bagged greens entirely and opting for whole heads of lettuce or loose bunches
Dan Dalton/KOTO – stock.adobe.com
The large vats that facilitate this washing are also an effective way to spread bacteria.
To prevent the proliferation of pathogens, greens must be kept cold; if lettuce is not consistently kept at these cooler temperatures throughout the supply chain, bacteria can easily breed and reach store shelves.
But refrigeration just slows bacteria growth, it doesn't kill them.
Washing greens is also ineffective at removing pathogens. In fact, doing so also double down on the danger, as doing so can introduce contamination from the sink, utensils, equipment, and the compromised hands of the washer themselves.
What's a leaf-eater to do? Consume carefully.
Consider ditching bagged greens entirely and opting for whole heads of lettuce or loose bunches. He recommends whole heads of lettuce or spinach, which have less surface area for contamination. Just rinse the leaves under cold running water to remove dirt and surface-level bacteria.
If you're bag or bust, Detwiler advises buyers to skip greens that appear wilted, slimy, or discolored and avoid those in packages that look wet, as these signs could indicate improper storage.
Further, avoid subjecting your greens to drastic temperature changes. Keeping them in a hot environment or even on the counter at room temperature can create an environment for bacteria to grow and spoilage to take hold.
Finally, stay up to date on recalls and double-checking expiration dates, only buying greens that you plan to use within 2 days.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Liver-Assessment Tool Hepatoscope® Steadily Expands Installed-Base Validating Its Clinical and Commercial Viability
Liver-Assessment Tool Hepatoscope® Steadily Expands Installed-Base Validating Its Clinical and Commercial Viability

Yahoo

time10 hours ago

  • Yahoo

Liver-Assessment Tool Hepatoscope® Steadily Expands Installed-Base Validating Its Clinical and Commercial Viability

E-Scopics' Ultraportable, Software-Based Hepatoscope In Use Across Leading Institutions and Clinics AIX-EN-PROVENCE, France, June 20, 2025--(BUSINESS WIRE)--After successfully exhibiting its unique software-based liver assessment tool Hepatascope at the DDW Convention in San Diego and the EASL Conference in Amsterdam, the France-based medical ultrasound company E-Scopics will demonstrate the technology at the June 2025 American Diabetes Association Conference in Chicago. The technology is seeing expanded adoption, with the company reporting that it has established the technology in a number of important sites in the US and Europe, validating its clinical and commercial viability. In the span of a few short years, the company has successfully adapted its premium ultrafast imaging point-of-care systems into GI and primary care, putting the system into the hands of a growing number of users who recognize its clinical value and importance in improving the standard of care for patients. In the process, E-Scopics has completely disrupted the field of portable ultrasound by leveraging proprietary technology using software-based image reconstruction. In 2023 E-Scopics began to commercialize its first product, Hepatoscope, both in the USA and in EMEA countries. The company's mid-term goal is to increase its footprint globally, starting its expansion to most European countries, where patients at risk of chronic liver diseases are. Hepatoscope continues to gain recognition as an alternative to legacy technology, from major institutions and all-size healthcare institutions across the USA. E-Scopics Founder and CEO Claude Cohen-Bacrie, who brings deep experience developing and taking to market cutting-edge ultrasound technologies, commented, "Our ambition is to bring premium quantitative ultrasound modalities and tools at the point-of-care, in the hands of non-ultrasound expert users, for the benefit of healthcare systems and patients. Making patients' journey and care pathways simpler and more efficient is our priority. We are so pleased that our backers- both leading users who understand the clinical and business partners who get the commercial potential, are in it for the long haul- and really excited about it." The company recognized MASLD was on the rise globally, and the need to bring the healthcare community a less expensive, more portable, and easier-to-use tool to accurately screen for the disease. It was very deliberate, developing a tool that was simple to use and reducing costs. The Hepatoscope application can easily be loaded onto a consumer laptop or tablet and rapidly deployed in the field. In addition to ease-of-use, the company saw Ultrasound-as-a-Service model as means to open access to any clinic via an affordable monthly or pay-per-use subscription, innovating on the business side. Cohen-Bacrie continued, "We see a healthier patient population coming out of a world where there is healthy business competition which drives innovation. We would not be talking about elastography outside of this important competitive environment. Especially where liver assessment is concerned, patients really need it, clinicians are asking for better and more affordable tools, and the FDA and payers endorse it." The numbers bear the need out. Approximately 1.5 million patients have been diagnosed with metabolic dysfunction associated steatohepatitis (MASH) in the U.S., and it is estimated that the precursor to MASH—metabolic dysfunction-associated steatotic liver disease or MASLD—will affect more than half of all American adults by 2040. The MASLD spectrum ranges from a simple, generally nonprogressive fat buildup in the liver all the way to MASH, which can lead to cirrhosis, hepatocellular carcinoma, and death. The economic burden attributed to effects of MASLD in the U.S. exceeds $100 billion annually. Therefore, it is crucial to identify these patients and take care of them as early as possible. "As consumers we've become conditioned to expect the latest and greatest personal computing and communications tools, they simply make us more efficient in day-to-day tasks, said Dr. Julio Gutierrez, Associate Professor of Medicine at Scripps Center for Organ Transplant in La Jolla, CA and an early adopter of Hepatoscope. "I think of E-Scopics like Apple and have come to expect continuous innovation, and the clinical impact has been significant." Dr. Cyrielle Caussy MD, PhD, Professor of Nutrition and an Endocrinologist-Diabetologist at Lyon 1 University and Lyon South Hospital in France, asserted, "In the endocrine and diabetology practice, approximately 80% of patients screened show low liver stiffness, which means they can be reassured without further referral or testing. By reducing the time between initial screening and specialty care, the Hepatoscope improves both the efficiency and quality of patient management. For high-risk patients, we can initiate care pathways much earlier, potentially slowing or halting the progression of liver disease. At the same time, for low-risk individuals, we avoid unnecessary referrals, which frees up resources and improves overall healthcare system efficiency. Importantly, patients appreciate the immediate feedback they receive, which encourages compliance with treatment plans and lifestyle modifications." E-Scopics will demonstrate Hepatoscope at the American Diabetes Association annual conference in Chicago in Booth #3527. Visitors may walk in and also book a time by emailing About E-Scopics: E-Scopics S.A.S is a MedTech company headquartered in France. The company advances the accessibility, affordability, and ease of use of premium ultrasound tools at the point of care. Its agile software platform has dematerialized and automated ultrasound imaging technologies. Ultrasound-as-a-Service products derived from this platform are specific Apps commercialized with pay-per-use or subscription business models. The company's first product, the Hepatoscope, leverages quantitative imaging capabilities to help any clinician assess liver fibrosis and steatosis—important markers of MASLD-MASH—non-invasively at the bedside. To learn more, visit View source version on Contacts Dan ConleyBeacon Communicationsdconley@ 312-593-8461 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Liver-Assessment Tool Hepatoscope® Steadily Expands Installed-Base Validating Its Clinical and Commercial Viability
Liver-Assessment Tool Hepatoscope® Steadily Expands Installed-Base Validating Its Clinical and Commercial Viability

Business Wire

time10 hours ago

  • Business Wire

Liver-Assessment Tool Hepatoscope® Steadily Expands Installed-Base Validating Its Clinical and Commercial Viability

AIX-EN-PROVENCE, France--(BUSINESS WIRE)--After successfully exhibiting its unique software-based liver assessment tool Hepatascope at the DDW Convention in San Diego and the EASL Conference in Amsterdam, the France-based medical ultrasound company E-Scopics will demonstrate the technology at the June 2025 American Diabetes Association Conference in Chicago. The technology is seeing expanded adoption, with the company reporting that it has established the technology in a number of important sites in the US and Europe, validating its clinical and commercial viability. In the span of a few short years, the company has successfully adapted its premium ultrafast imaging point-of-care systems into GI and primary care, putting the system into the hands of a growing number of users who recognize its clinical value and importance in improving the standard of care for patients. In the process, E-Scopics has completely disrupted the field of portable ultrasound by leveraging proprietary technology using software-based image reconstruction. In 2023 E-Scopics began to commercialize its first product, Hepatoscope, both in the USA and in EMEA countries. The company's mid-term goal is to increase its footprint globally, starting its expansion to most European countries, where patients at risk of chronic liver diseases are. Hepatoscope continues to gain recognition as an alternative to legacy technology, from major institutions and all-size healthcare institutions across the USA. E-Scopics Founder and CEO Claude Cohen-Bacrie, who brings deep experience developing and taking to market cutting-edge ultrasound technologies, commented, 'Our ambition is to bring premium quantitative ultrasound modalities and tools at the point-of-care, in the hands of non-ultrasound expert users, for the benefit of healthcare systems and patients. Making patients' journey and care pathways simpler and more efficient is our priority. We are so pleased that our backers- both leading users who understand the clinical and business partners who get the commercial potential, are in it for the long haul- and really excited about it.' The company recognized MASLD was on the rise globally, and the need to bring the healthcare community a less expensive, more portable, and easier-to-use tool to accurately screen for the disease. It was very deliberate, developing a tool that was simple to use and reducing costs. The Hepatoscope application can easily be loaded onto a consumer laptop or tablet and rapidly deployed in the field. In addition to ease-of-use, the company saw Ultrasound-as-a-Service model as means to open access to any clinic via an affordable monthly or pay-per-use subscription, innovating on the business side. Cohen-Bacrie continued, 'We see a healthier patient population coming out of a world where there is healthy business competition which drives innovation. We would not be talking about elastography outside of this important competitive environment. Especially where liver assessment is concerned, patients really need it, clinicians are asking for better and more affordable tools, and the FDA and payers endorse it.' The numbers bear the need out. Approximately 1.5 million patients have been diagnosed with metabolic dysfunction associated steatohepatitis (MASH) in the U.S., and it is estimated that the precursor to MASH—metabolic dysfunction-associated steatotic liver disease or MASLD—will affect more than half of all American adults by 2040. The MASLD spectrum ranges from a simple, generally nonprogressive fat buildup in the liver all the way to MASH, which can lead to cirrhosis, hepatocellular carcinoma, and death. The economic burden attributed to effects of MASLD in the U.S. exceeds $100 billion annually. Therefore, it is crucial to identify these patients and take care of them as early as possible. 'As consumers we've become conditioned to expect the latest and greatest personal computing and communications tools, they simply make us more efficient in day-to-day tasks, said Dr. Julio Gutierrez, Associate Professor of Medicine at Scripps Center for Organ Transplant in La Jolla, CA and an early adopter of Hepatoscope. 'I think of E-Scopics like Apple and have come to expect continuous innovation, and the clinical impact has been significant.' Dr. Cyrielle Caussy MD, PhD, Professor of Nutrition and an Endocrinologist-Diabetologist at Lyon 1 University and Lyon South Hospital in France, asserted, 'In the endocrine and diabetology practice, approximately 80% of patients screened show low liver stiffness, which means they can be reassured without further referral or testing. By reducing the time between initial screening and specialty care, the Hepatoscope improves both the efficiency and quality of patient management. For high-risk patients, we can initiate care pathways much earlier, potentially slowing or halting the progression of liver disease. At the same time, for low-risk individuals, we avoid unnecessary referrals, which frees up resources and improves overall healthcare system efficiency. Importantly, patients appreciate the immediate feedback they receive, which encourages compliance with treatment plans and lifestyle modifications.' E-Scopics will demonstrate Hepatoscope at the American Diabetes Association annual conference in Chicago in Booth #3527. Visitors may walk in and also book a time by emailing About E-Scopics: E-Scopics S.A.S is a MedTech company headquartered in France. The company advances the accessibility, affordability, and ease of use of premium ultrasound tools at the point of care. Its agile software platform has dematerialized and automated ultrasound imaging technologies. Ultrasound-as-a-Service products derived from this platform are specific Apps commercialized with pay-per-use or subscription business models. The company's first product, the Hepatoscope, leverages quantitative imaging capabilities to help any clinician assess liver fibrosis and steatosis—important markers of MASLD-MASH—non-invasively at the bedside. To learn more, visit

Food expert warns ‘one of the riskiest items in the grocery store' seems healthy but can make you deathly ill
Food expert warns ‘one of the riskiest items in the grocery store' seems healthy but can make you deathly ill

New York Post

time11 hours ago

  • New York Post

Food expert warns ‘one of the riskiest items in the grocery store' seems healthy but can make you deathly ill

Your good health habit could actually get you seriously sick — and you wouldn't know until it's too late. While experts unanimously agree that we should all be eating more fresh, whole foods, a food policy professor has a warning: Danger lurks in your grocery store's produce aisle. Not all fruits and veggies are created equal, and a popular choice for easy meals that save you time could come with the price of contamination. 3 Prewashed bagged greens are one of the riskiest items in the grocery store. Scott Habermann – 'Prewashed bagged greens remain one of the riskiest items in the grocery store,' Darin Detwiler, a professor of food policy at Northeastern University and author of 'Food Safety: Past, Present, and Predictions,' told Huffington Post. 'When you look at past outbreaks, bagged salads have been a leading cause of foodborne illness, with some outbreaks resulting in hospitalizations, kidney failure, and even death.' Those pre-mixed bagged salads can harbor pathogens like listeria, salmonella, and E. coli and pose a higher risk for contamination through the supply chain and are among the worst offenders for food safety. According to the Centers for Disease Control and Prevention, food poisoning symptoms from bacteria like listeria or E. coli — which cause infections in the gastrointestinal tract — include nausea, vomiting, fever, abdominal pain, and diarrhea. According to a 2024 report in the Journal of Foodborne Illness, leafy greens are credited with 'up to 9.2% of known pathogen-caused foodborne illnesses' in the U.S, resulting in over 2.3 million cases of illness each year. What makes these speedy veggies particularly dicey is that heat is required to kill pathogens — and salads are typically eaten raw, making it difficult to reduce the risk of foodborne illness once they reach consumers. Contamination of these mean greens can occur at different stages of production. Produce can be contaminated during lettuce collection by pathogens in the water, soil, or air, or by wild or domesticated animals. Leafy greens are sometimes grown near large-scale cattle operations, a proximity that increases the likelihood that E. coli, salmonella, and listeria could be introduced through contaminated irrigation water. 3 Produce can be contaminated during collection by pathogens in the water, soil, or air, or by wild or domesticated animals. Pormezz – Detwiler cites manure lagoons, large pits where livestock waste is stored, as a common source of food contamination. 'Runoff from manure lagoons can seep into irrigation canals and contaminate fields with deadly bacteria like E. coli,' he said. Post-harvest, lettuce can be compromised through human handling, contaminated equipment, or water used to remove soil. Typically, lettuces from various farms are processed in a centralized area, meaning your bag of greens is more of a menagerie of fetid potential than a single source. 'Greens from different farms are mixed, washed, and packaged together, so one contaminated leaf can impact thousands of bags across multiple states,' said Detwiler. 3 Consider ditching bagged greens entirely and opting for whole heads of lettuce or loose bunches Dan Dalton/KOTO – The large vats that facilitate this washing are also an effective way to spread bacteria. To prevent the proliferation of pathogens, greens must be kept cold; if lettuce is not consistently kept at these cooler temperatures throughout the supply chain, bacteria can easily breed and reach store shelves. But refrigeration just slows bacteria growth, it doesn't kill them. Washing greens is also ineffective at removing pathogens. In fact, doing so also double down on the danger, as doing so can introduce contamination from the sink, utensils, equipment, and the compromised hands of the washer themselves. What's a leaf-eater to do? Consume carefully. Consider ditching bagged greens entirely and opting for whole heads of lettuce or loose bunches. He recommends whole heads of lettuce or spinach, which have less surface area for contamination. Just rinse the leaves under cold running water to remove dirt and surface-level bacteria. If you're bag or bust, Detwiler advises buyers to skip greens that appear wilted, slimy, or discolored and avoid those in packages that look wet, as these signs could indicate improper storage. Further, avoid subjecting your greens to drastic temperature changes. Keeping them in a hot environment or even on the counter at room temperature can create an environment for bacteria to grow and spoilage to take hold. Finally, stay up to date on recalls and double-checking expiration dates, only buying greens that you plan to use within 2 days.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store